Mohamed O. Radwan

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

Belgin Sever, Mehlika Dilek Altıntop, Mohamed O. Radwan et al. · European Journal of Medicinal Chemistry · 2019 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety

Mehlika Dilek Altıntop, Halil I. Ciftci, Mohamed O. Radwan et al. · Molecules · 2017 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors

Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemır et al. · Molecules · 2020 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities

Halil I. Ciftci, Safiye Emirdağ, Taha F. S. Ali et al. · Biological and Pharmaceutical Bulletin · 2018 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents

Nilüfer Bayrak, Hatice Yıldırım, Mahmut Yıldız et al. · Bioorganic Chemistry · 2019 · 40 citations

Pharmacy, Medicinal Chemistry, Oncology +17